-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Jr9CVwsStxCjKs92H35Isk0YrY8SQPfPbthDJlcVhrVsJ40xRPFjNHhV/AKf6/9H ZMhIcCGSaYM+i/TSYwa8Tw== 0001193125-05-028263.txt : 20050214 0001193125-05-028263.hdr.sgml : 20050214 20050214103901 ACCESSION NUMBER: 0001193125-05-028263 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20050214 DATE AS OF CHANGE: 20050214 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: CONOR MEDSYSTEMS INC CENTRAL INDEX KEY: 0001108271 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 943350973 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-80418 FILM NUMBER: 05603927 BUSINESS ADDRESS: STREET 1: 1003 HAMILTON COURT CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: (650) 614-4100 MAIL ADDRESS: STREET 1: 1003 HAMILTON COURT CITY: MENLO PARK STATE: CA ZIP: 94025 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Litvack Frank CENTRAL INDEX KEY: 0001310715 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: BUSINESS PHONE: (650) 614-4100 MAIL ADDRESS: STREET 1: C/O CONOR MEDSYSTEMS, INC. STREET 2: 1003 HAMILTON COURT CITY: MENLO PARK STATE: CA ZIP: 94025 SC 13G 1 dsc13g.htm SCHEDULE 13G Schedule 13G

OMB APPROVAL

OMB Number:

   3235-0145

Expires:

   December 31, 2005

Estimated average burden

hours per response . . . 11

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

 

SCHEDULE 13G

 

 

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No.         )*

 

 

 

 

 

Conor Medsystems, Inc.

(Name of Issuer)

 

 

Common Stock

(Title of Class of Securities)

 

 

208264 10 1

                                (CUSIP Number)                                

 

 

December 31, 2004

(Date of Event Which Requires Filing of This Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

¨ Rule 13d-1(b)

 

¨ Rule 13d-1(c)

 

x Rule 13d-1(d)

 

 

*   The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

Page 1 of 5 pages


CUSIP No. 208264 10 1

 

  1.  

Name of Reporting Persons

I.R.S. Identification No(s). of above person(s) (entities only)

 

Frank Litvack

   
  2.  

Check the Appropriate Box if a Member of a Group (See Instructions)

(a)

(b)

   
  3.  

SEC USE ONLY

 

   
  4.  

Citizenship or Place of Organization

 

United States

   

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person With:

 

  5.    Sole Voting Power:

 

      1,798,020 (1)


  6.    Shared Voting Power:

 

      1,083,304 (2)


  7.    Sole Dispositive Power:

 

      1,798,020 (1)


  8.    Shared Dispositive Power:

 

      1,083,304 (2)

  9.  

Aggregate Amount Beneficially Owned by Each Reporting Person:

 

2,881,324

   
10.  

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

 

 

   
11.  

Percent of Class Represented by Amount in Row (9):

 

8.4%

   
12.  

Type of Reporting Person (See Instructions):

 

IN

   

 

(1) Consists of shares issuable pursuant to options exercisable within 60 days of December 31, 2004.

 

(2) Includes 753,258 shares held by Calmedica Capital, L.P., of which the Reporting Person is the general partner, 315,000 shares held by Calmedica International LLC, of which the Reporting Person is a member. Also includes 15,046 shares issuable pursuant to warrants held by Calmedia Capital, L.P., which are exercisable within 60 days of December 31, 2004.

 

Page 2 of 5 pages


Item 1.(a)

   Name of Issuer Conor Medsystems, Inc.          

(b)

   Address of Issuer’s Principal Executive Offices          
    

1003 Hamilton Court

Menlo Park, CA 94025

         

Item 2.(a)

   Name of Person Filing          
     Frank Litvack          

(b)

   Address of Principal Business Office or, if none, Residence          
    

1003 Hamilton Court

Menlo Park, CA 94025

         

(c)

   Citizenship          
     USA          

(d)

   Title of Class of Securities          
    

Common Stock

         

(e)

   CUSIP Number     208264 10 1          

Item 3.    

   If this statement is filed pursuant to §§240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a:     
          Not Applicable          

 

Page 3 of 5 pages


Item 4.

   Ownership          
     Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
     (a)    Amount Beneficially Owned:          
          2,881,324          
     (b)    Percent of Class:          
          8.4%          
     (c)    Number of shares as to which the person has:          
          (i)    Sole power to vote or to direct the vote: 1,798,020 (1)          
          (ii)    Shared power to vote or to direct the vote: 1,083,304 (2)          
          (iii)    Sole power to dispose or to direct the disposition of: 1,798,020 (1)          
          (iv)    Shared power to dispose or to direct the disposition of: 1,083,304 (2)          

Item 5.

   Ownership of Five Percent or Less of a Class     
          If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ¨.

Item 6.

   Ownership of More than Five Percent on Behalf of Another Person          
          Not Applicable          

Item 7.

   Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.
         

Not Applicable

         

Item 8.

   Identification and Classification of Members of the Group          
          Not Applicable          

Item 9.

   Notice of Dissolution of a Group          
          Not Applicable          

Item 10.

   Certification          
          Not Applicable          

(1) Consists of shares issuable pursuant to options exercisable within 60 days of December 31, 2004.

 

(2) Includes 753,258 shares held by Calmedica Capital, L.P., of which the Reporting Person is the general partner, 315,000 shares held by Calmedica International LLC, of which the Reporting Person is a member. Also includes 15,046 shares issuable pursuant to warrants held by Calmedia Capital, L.P., which are exercisable within 60 days of December 31, 2004.

 

Page 4 of 5 pages


 

SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

February 11, 2005
Date
/s/    FRANK LITVACK
Signature
Frank Litvack
Name/Title

 

Page 5 of 5 pages

-----END PRIVACY-ENHANCED MESSAGE-----